Epidemiological investigation of venomous snakebites in Yunnan Province.

IF 4.6 Q2 TOXICOLOGY
Frontiers in toxicology Pub Date : 2025-08-06 eCollection Date: 2025-01-01 DOI:10.3389/ftox.2025.1609487
Qinfen Gao, Yajun Teng, Chao Xiao, Rui Zeng, Bin Han, Hong Gao, Jianhai Wang, Xiaoyan Li, Canju Yang, Jianneng Dai, Chunxi Li, Qunyan Huang, Zengzheng Li, Wei Zhang
{"title":"Epidemiological investigation of venomous snakebites in Yunnan Province.","authors":"Qinfen Gao, Yajun Teng, Chao Xiao, Rui Zeng, Bin Han, Hong Gao, Jianhai Wang, Xiaoyan Li, Canju Yang, Jianneng Dai, Chunxi Li, Qunyan Huang, Zengzheng Li, Wei Zhang","doi":"10.3389/ftox.2025.1609487","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Snakebite envenoming constitutes a substantial public health concern worldwide. Yunnan Province, The lack of comprehensive epidemiological data on snakebite in Yunnan affects research, diagnostic, and treatment advancements. This research evaluates patient demographics, seasonal patterns, snake species associated with the disease, and treatment approaches to guide preventative and therapeutic initiatives in the province.</p><p><strong>Methods: </strong>This retrospective analysis reviewed clinical records of venomous snakebite cases admitted to hospitals in 16 cities within Yunnan Province from January 2022 to November 2024. Collected data covered diverse aspects, including patient demographics (age, sex), circumstances of the bite (location, size, and time), species identification, observed clinical symptoms, treatments administered (e.g., antivenin and alternative therapies), and hospital stay duration. Subsequently, the effect of different therapeutic measures on these patients' hospital stays was analyzed.</p><p><strong>Results: </strong>A total of 2,112 venomous snakebite cases were recorded, with incidence rates rising annually: 406/46.73 million in 2022, 825/46.73 million in 2023, and 886/46.73 million in 2024. <i>Ovophis</i> (52.08%) and <i>Trimeresurus</i> (28.74%) species were predominant. These findings align with the annual distribution of anti-venom serum administered to affected individuals. Most incidents occurred during June to September, primarily in mountainous and forested areas or paddy fields, comprising approximately 52.40% of the total cases. Nearly all bites (99.05%) were localized to the limbs, presenting with swelling and pain as the dominant clinical features. Statistical analysis revealed that factors such as incision and debridement, additional anti-venom serum, fibrinogen supplementation, plasma administration, Ji Desheng Snake Medicine, and magnesium sulfate compresses were significantly associated with extended hospital stays (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Snake bites in Yunnan Province mainly affect young and middle-aged agricultural workers in rural and mountainous areas. The predominant venomous snakes in the area are hemotoxic. The findings emphasize the necessity of early intervention with antivenom and adjunctive therapies, including fibrinogen and plasma administration. Delays in getting medical help or improper treatment can lead to longer hospital stays.</p>","PeriodicalId":73111,"journal":{"name":"Frontiers in toxicology","volume":"7 ","pages":"1609487"},"PeriodicalIF":4.6000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364869/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/ftox.2025.1609487","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Snakebite envenoming constitutes a substantial public health concern worldwide. Yunnan Province, The lack of comprehensive epidemiological data on snakebite in Yunnan affects research, diagnostic, and treatment advancements. This research evaluates patient demographics, seasonal patterns, snake species associated with the disease, and treatment approaches to guide preventative and therapeutic initiatives in the province.

Methods: This retrospective analysis reviewed clinical records of venomous snakebite cases admitted to hospitals in 16 cities within Yunnan Province from January 2022 to November 2024. Collected data covered diverse aspects, including patient demographics (age, sex), circumstances of the bite (location, size, and time), species identification, observed clinical symptoms, treatments administered (e.g., antivenin and alternative therapies), and hospital stay duration. Subsequently, the effect of different therapeutic measures on these patients' hospital stays was analyzed.

Results: A total of 2,112 venomous snakebite cases were recorded, with incidence rates rising annually: 406/46.73 million in 2022, 825/46.73 million in 2023, and 886/46.73 million in 2024. Ovophis (52.08%) and Trimeresurus (28.74%) species were predominant. These findings align with the annual distribution of anti-venom serum administered to affected individuals. Most incidents occurred during June to September, primarily in mountainous and forested areas or paddy fields, comprising approximately 52.40% of the total cases. Nearly all bites (99.05%) were localized to the limbs, presenting with swelling and pain as the dominant clinical features. Statistical analysis revealed that factors such as incision and debridement, additional anti-venom serum, fibrinogen supplementation, plasma administration, Ji Desheng Snake Medicine, and magnesium sulfate compresses were significantly associated with extended hospital stays (P < 0.05).

Conclusion: Snake bites in Yunnan Province mainly affect young and middle-aged agricultural workers in rural and mountainous areas. The predominant venomous snakes in the area are hemotoxic. The findings emphasize the necessity of early intervention with antivenom and adjunctive therapies, including fibrinogen and plasma administration. Delays in getting medical help or improper treatment can lead to longer hospital stays.

Abstract Image

Abstract Image

Abstract Image

云南省毒蛇咬伤流行病学调查。
背景:蛇咬伤是世界范围内严重的公共卫生问题。云南省蛇咬伤综合流行病学资料的缺乏影响了研究、诊断和治疗的进展。本研究评估了患者人口统计、季节模式、与该病相关的蛇种以及指导该省预防和治疗举措的治疗方法。方法:回顾性分析2022年1月至2024年11月云南省16个城市医院毒蛇咬伤病例的临床资料。收集到的数据涵盖各个方面,包括患者人口统计(年龄、性别)、咬伤情况(位置、大小和时间)、物种鉴定、观察到的临床症状、给予的治疗(例如抗蛇毒血清和替代疗法)以及住院时间。随后,分析不同治疗措施对患者住院时间的影响。结果:共记录毒蛇咬伤2112例,发病率呈逐年上升趋势:2022年为4.06 / 4673万例,2023年为8.25 / 4673万例,2024年为886/ 4673万例。优势种为卵蠓(52.08%)和Trimeresurus(28.74%)。这些发现与受影响个体抗蛇毒血清的年度分布相一致。大多数病例发生在6月至9月,主要发生在山区和林区或稻田,约占病例总数的52.40%。几乎所有的咬伤(99.05%)都局限于四肢,以肿胀和疼痛为主要临床特征。统计分析显示,切口清创、加用抗蛇毒血清、补充纤维蛋白原、血浆给药、吉德生蛇药、硫酸镁敷药等因素与延长住院时间有显著相关性(P < 0.05)。结论:云南省蛇咬伤以农村和山区中青年农业劳动者为主。该地区主要的毒蛇是含血毒液的。研究结果强调了抗蛇毒血清早期干预和辅助治疗的必要性,包括纤维蛋白原和血浆给药。延迟获得医疗帮助或治疗不当会导致住院时间更长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信